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Abstract
Purpose Existing data from prospective cohort studies on
dairy consumption and cardiovascular diseases are incon-
sistent. Even though the association between total dairy and
cardiovascular diseases has been studied before, little is
known about the effect of different types of dairy products
on cardiovascular diseases (CVD). The objective of this
study was to examine the relationship between (type of)
dairy intake and CVD mortality and all-cause mortality in a
Dutch population.
Methods We examined the relationship between dairy
intake and CVD mortality and all-cause mortality in 1956
participants of the Hoorn Study (aged 50–75 years), free of
CVD at baseline. Hazard ratios with 95 % CIs were
obtained for CVD mortality and all-cause mortality per
standard deviation (SD) of the mean increase in dairy
intake, with adjustment for age, sex, BMI, smoking,
education, total energy intake, alcohol consumption,
physical activity, and dietary intakes.
Results During 12.4 years of follow-up, 403 participants
died, of whom 116 had a fatal CVD event. Overall dairy
intake was not associated with CVD mortality or all-cause
mortality. Each SD increase in high-fat dairy intake was
associated with a 32 % higher risk of CVD mortality (95 %
CI; 7–61 %).
Conclusion In this prospective cohort study, the intake of
high-fat dairy products was associated with an increased
risk of CVD mortality.
Keywords Dairy  Cardiovascular diseases  Mortality 
Prospective
Introduction
Cardiovascular diseases (CVD) are a major cause of death
worldwide, claiming 17 million lives a year. Risk factors
for CVD are smoking, overweight, hypertension, high
plasma cholesterol levels, and diabetes mellitus [1]. Die-
tary recommendations for the prevention of CVD include
reduced intake of saturated fat intake, for example by
means of consuming low-fat dairy instead of whole-fat
dairy [1].
Low-fat dairy foods are also one of the main compo-
nents of the Dietary Approaches to Stop Hypertension
(DASH) diet, which has been shown to lower blood pres-
sure [2]. However, the beneficial effect could not be
ascribed to the low-fat dairy products only, since the diet
comprised many other components that are beneficial to
health, such as fibers, fruits, and vegetables. Fermented
dairy products may also have a beneficial effect on CVD,
by reducing the cholesterol concentrations in the blood [3].
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Among results of studies assessing the relationship
between overall dairy intake and CVD, discrepancy exists.
Some observational studies reported no association
between dairy intake and CVD [4–8], while another study
found an increased risk on developing CVD [9]. There are
furthermore studies that found an inverse association
between dairy intake and CVD [10–12]. There is growing
evidence for a beneficial effect of dairy consumption on
blood pressure [9, 13–15].
Despite the abundance of information, it is difficult to draw
conclusions from the different studies. Dairy comprises many
products, such as milk, cheese, yoghurt, and desserts. It is
currently unclear how these specific dairy products like high-
fat dairy, low-fat dairy, cheese, or fermented dairy are asso-
ciated with CVD. This is also supported by review articles
and meta-analysis papers [16–21]. Some state that there is no
clear evidence that higher dairy food consumption is con-
sistently associated with a higher risk of CVD [17–19].
Others conclude that there is fairly convincing evidence that
milk and dairy consumption is associated with an increase in
survival in Western communities [20].
Gibson et al. [18] conclude that the studies available for
examining the relationship between dairy food consumption
and coronary heart disease (CHD) vary too much in design,
quality, and dietary assessment methodology. Meta-analyses
were mainly dominated by American studies, and often, no
distinction was made between the different types of dairy.
Therefore, the purpose of the present study was to
determine the relationship between (type of) dairy intake
and CVD mortality and all-cause mortality in a Dutch
cohort of men and women aged 50–75 years. Total dairy
and the different subcategories (high-fat dairy, low-fat
dairy, milk, milk and milk products, fermented dairy and
cheese) were taken into account. Both CVD mortality and
all-cause mortality were used as main outcomes. In the
Netherlands, the consumption of dairy is naturally high and
a large variety of dairy products is consumed. Only few
studies have evaluated the relationship between dairy and
dairy categories and the risk of CVD mortality.
Subjects and methods
Study population
The Hoorn Study is a Dutch cohort study of diabetes and
diabetes complications among the general population,
which began in 1989. The study is conducted in 2,484
Caucasian men and women aged 50–75 years. The cohort
and baseline measurements are described in detail else-
where [22].
For this study, 477 subjects were excluded because they
had CVD at baseline and 51 subjects were excluded
because of missing information on dietary intake. There-
fore, the analyses were performed in 1956 subjects (857
men and 1,099 women).
Written consent was obtained from all participants. The
study was approved by the Ethics Committee of the VU
Medical Center.
Baseline measurements
Weight and height were measured, and body mass index
(BMI) was calculated as weight (kg) divided by height
squared (m2). Blood pressure was measured on the right
arm with a random-zero sphygmomanometer (Hawksley–
Gelman Ltd, Lancing, United Kingdom) while subjects
were sitting.
Information on lifestyle factors was obtained by a self-
administered questionnaire, which was checked by a per-
sonal interview. Smoking status was categorized as current
smoker, ex-smoker, or non-smoker. Physical activity was
expressed in number of hours of physical activity per day.
The activities included sports, bicycling, gardening, walk-
ing, doing odd jobs, and housekeeping. Alcohol intake was
divided into four categories: non-drinker, B10, 10–30, and
C30 g/day. There were three categories of educational
level: low, medium, and high.
Assessment of dairy consumption
To assess dietary intakes of the participants, a 92-item
validated semi-quantitative food-frequency questionnaire
(FFQ) was used [23], which included the dairy consump-
tion. The participants filled in the questionnaire at home,
and the FFQs were checked in the research center for
completeness.
Low-fat dairy was defined as milk products with a fat
content\2.0/100 g or cheese products with a fat content\20/
100 g. High-fat dairy was defined as milk products with a fat
content[2.0/100 g or cheese products with a fat content[20/
100 g. High-fat dairy was further divided into desserts
(yoghurt, curds, custards, and ice-cream) and non-desserts
(milk, cheese, porridge, and cream) [24]. The category ‘‘milk
and milk products’’ included all kind of milk, yoghurt, coffee
creamer, curd, pudding, porridge, and cream. The category
‘‘milk’’ included skimmed, semi-skimmed, and whole milk.
The category ‘‘fermented dairy’’ included all fermented
products, such as yoghurt, buttermilk, curds, and cheese
products. The category ‘‘cheese’’ included all kinds of cheese,
that is, soft cheese and hard cheese.
Outcome measurements
Information on mortality was obtained from the general
practitioners and the local hospital. Causes of death were
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coded according to the International Classification of Dis-
eases, Injuries, and Causes of Death, ninth revision (ICD-9).
Fatal CVD was defined as ICD codes 390–459 (diseases of
the circulatory system).
Data on fatal CVD were complete until 2005. The mean
follow-up in years was 12.4 (24,312 person years).
Statistical analysis
Baseline characteristics are displayed for the total study
population. Cox proportional hazard models were used to
estimate hazard ratios (HRs with 95 % CIs) for fatal CVD
and all-cause mortality. Because of the limited cases for
fatal CHD (n = 50) and stroke (n = 21), these endpoints
were not analyzed separately.
The HRs were estimated per standard deviation (SD) of
the mean of dairy product intake.
The basic model was not adjusted for any confounder
(model 1). Model 2 included age (continuous) and sex.
Subsequently, a multivariate analysis (model 3) was per-
formed with adjustment for age, sex, BMI (continuous),
smoking (3 categories), educational level (3 categories),
total energy intake (continuous), and alcohol consumption (4
categories). Further adjustments (model 4) were then made
for physical activity (continuous) and for intakes of meat,
fish, bread, vegetables, fruit, coffee, and tea (continuous).
The statistical analyses were performed by using SAS
software (version 9.2; SAS Institute, Cary, NC, USA).
Results
Baseline characteristics
Baseline characteristics of the study population are shown
in Table 1. The mean age of this population was 61.6 years
and 43.8 % was male.
Dairy consumption
The median intake of total dairy products in this population
was 425 g/day. Median intakes in the total population of
high-fat dairy, low-fat dairy, fermented dairy, milk and
milk products, milk, and cheese were 101, 250, 181, 394,
108, and 24 g/day, respectively (Fig. 1 for median intakes
of dairy products and interquartile ranges).
The SDs of the mean intake (shown in Table 1) were
271 g/day for total dairy, 179 g/day for high-fat dairy,
260 g/day for low-fat dairy, 268 g/day for milk and milk
products, 202 g/d for milk, 182 g/day for fermented dairy,
and 22 g/day for cheese.
Table 1 Mean (±SD) baseline characteristics and dietary intakes of
1956 men and women from the Hoorn Study
Characteristic Value
N 1,956
Age (year) 61.1 (7.2)
Sex (% male) 43.8
BMI (kg/m2) 26.5 (3.5)
Physical activity (hour/day) 4.4 (2.7)
Educational level
Low (%) 80.2
Medium (%) 13.6
High (%) 6.2
Current smoker (%) 31.5
Alcohol (g/day) 9.0 (12.2)
Systolic BP (mmHg) 135 (20)
Diastolic BP (mmHg) 82 (10)
Serum total cholesterol (mmol/L) 6.6 (1.2)
LDL-cholesterol (mmol/L) 4.6 (1.1)
HDL-cholesterol (mmol/L) 1.3 (0.4)
NDD (%) 6.1
Known diabetes (%) 2.8
Hypertension (%) 26.0
Dietary intakes
Energy intake (kcal/day) 2,072 (587)
Total dairy (g/day)a 466.0 (270.9)
High-fat dairy (g/day)b 169.3 (178.5)
Low-fat dairy (g/day)c 295.3 (260.4)
Fermented dairy (g/day)d 218.2 (182.1)
Milk and milk products (g/day)e 430.0 (267.5)
Milk (g/dday)f 166.3 (202.4)
Cheese (g/day)g 30.1 (21.8)
Meat (g/day) 120.8 (59.8)
Fish (g/day) 18.1 (29.0)
Bread (g/day) 128.9 (59.9)
Vegetables (g/day) 108.3 (47.4)
Fruit (g/day) 229.5 (152.3)
Fiber (g/day) 27.2 (7.8)
Coffee (mL/day) 531.5 (290.0)
Tea (mL/day) 296.9 (251.4)
Total fat (g/day) 95.4 (33.2)
Saturated fat (g/day) 40.1 (14.7)
Total protein (g/day) 75.1 (21.2)
Total calcium (mg/day) 1,091 (409)
BP blood pressure, NDD newly detected diabetes
a Includes all dairy products, except butter
b Defined as all milk products with a fat content[2.0/100 g or cheese products
with a fat content [20 g/100 g
c Defined as all milk products with a fat content\2.0/100 g or cheese products
with a fat content \20/100 g
d Includes all fermented products, such as yogurt, buttermilk, curds, and
cheese products
e Includes all kinds of milk, yoghurt, coffee creamer, curd, pudding, porridge,
and cream (both low-fat and high-fat)
f Includes all milk: skimmed, semi-skimmed, and whole milk
g Includes soft cheese and hard cheese (both low-fat and high-fat)
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Dairy intake and fatal CVD
Until January 2005, 403 subjects died, of whom 116 had a
fatal CVD event.
No association was found between total dairy intake and
CVD mortality (multivariate HR, 1.18; 95 % CI, 0.96,
1.44). For high-fat dairy, however, each SD increase in
intake was significantly associated with a 32 % higher risk
of CVD mortality (95 % CI, 7, 61 %) (Table 2). Additional
adjustment for low-fat dairy increased the HR even further
(HR, 1.38; 95 % CI, 1.10, 1.72, data not shown in tables).
Further adjustments for LDL-cholesterol, HDL-cholesterol,
or hypertension only increased the HR further (data not
shown in tables).
When physical activity was omitted from model 4, since
255 participants had missing values on physical activity,
the HR for each SD increase in high-fat dairy was 1.24
(95 % CI, 1.03, 1.49, data not shown in tables).
Additional adjustment for saturated fat intake slightly
weakened the results (HR, 1.29; 95 % CI, 1.04, 1.59, data
not shown in tables), but this association remained statis-
tically significant. Additional adjustments for total fat,
protein, or calcium did not change the results (data not
shown in tables).
Further division of high-fat dairy products into desserts
(33 %) and non-desserts (66 %) demonstrated no statisti-
cally significant association between desserts and CVD
mortality (multivariate HR per SD (77.8 g/day) increase,
1.10; 95 % CI, 0.90, 1.35). On the other hand, consumption
of non-desserts high-fat dairy was significantly associated
with an increased risk of CVD mortality (HR per SD
(145.5 g/day) increase, 1.28; 95 % CI, 1.06, 1.55).
No statistically significant association was found between
low-fat dairy and CVD mortality (Table 2). Furthermore,
no statistically significant association was found between
fermented dairy and CVD mortality and between cheese
and CVD mortality.
Adjusting for energy according to the residual method
of Walter Willett [25] gave identical results (data not
shown).
Dairy intake and total mortality
There was no significant relationship between any of the
dairy categories and total mortality. A significant inverse
association was found between low-fat dairy and total
mortality, fermented dairy and total mortality, and between
cheese and total mortality in the crude model only. After
further adjustments, the HRs did not remain statistically
significant (Table 3).
Discussion
In this cohort study among 1956 Dutch men and women aged
50–75 years, a positive association was found between high-
fat dairy intake and the risk of CVD mortality.
Several observational studies have evaluated the asso-
ciation between dairy product intake and CVD outcomes
[4, 8, 9, 11–14, 24, 26, 27]. The results of these studies
were inconsistent, possibly because of the heterogeneity of
the population and the differences in design and dietary
assessment methodology used by the various studies, as
well as the exposures and outcomes studied. Dairy intake is
Fig. 1 Median intakes and
interquartile ranges of dairy
products in g/day. IQR
interquartile range (p 25, p 75)
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a rather heterogeneous exposure, and little is known about
specific types of dairy foods in relation to CVD.
Total dairy was not associated with CVD mortality and
all-cause mortality in this study. A previous study within
the Hoorn Study [24] showed that the consumption of high-
fat dairy was significantly inversely associated with car-
diovascular risk factors such as BMI and lipid levels, which
may seem inconsistent with our current results. However,
the cross-sectional associations are likely to be disturbed
by reversed causation [24], a phenomenon which is
excluded in longitudinal studies. Our current results on
mortality are in line with an earlier prospective analysis of
the Hoorn Study, where no association was found between
total dairy intake and changes in cardiovascular risk factors
[27]. No distinction was made between different types of
dairy in this study.
In the present study, high-fat dairy intake was associated
with an increased risk of CVD mortality. Dairy foods, and
especially high-fat dairy, contribute to the intake of satu-
rated fat. Especially longer chain saturated fat has previ-
ously been associated with higher incidence of CHD [28].
Moreover, saturated fatty acids raise the LDL-cholesterol
concentration in the blood, which is one of the main risk
factors for CVD. A recent study of Goldbohm et al. [29]
found that dairy fat intake was associated with slightly
increased all-cause and ischemic heart disease mortality
rates. Further evidence to support our positive results on
high-fat dairy and CVD mortality came from ecological
studies [30, 31] and controlled feeding studies finding
associations on LDL-cholesterol [32, 33]. To explore
whether the positive association between high-fat dairy and
CVD mortality can be attributed to fat or more sugar
containing products, we split our analyses by desserts.
Increased risks for CVD were only found in the ‘‘non-
desserts’’ category. This strengthened our suggestion that it
is potentially the high amount of fat that causes this high
Table 2 Hazard ratios (HRs) and 95 % CIs of fatal CVD per SD increase of dairy intake
Fatal CVD (n = 116)*
Model 1a Model 2b Model 3c Model 4d
Total dairye 1.07 (0.90, 1.28)
P = 0.46
1.04 (0.88, 1.23)
P = 0.65
1.06 (0.88, 1.29)
P = 0.54
1.18 (0.96, 1.44)
P = 0.11
High-fat dairyf 1.19 (1.03, 1.39)
P = 0.02
1.16 (1.00, 1.35)
P = 0.06
1.19 (1.01, 1.41)
P = 0.04
1.32 (1.07, 1.61)
P = 0.009
Low-fat dairyg 0.93 (0.77, 1.12)
P = 0.42
0.93 (0.78, 1.12)
P = 0.45
0.94 (0.78, 1.14)
P = 0.52
1.01 (0.83, 1.23)
P = 0.96
Milk and milk productsh 1.08 (0.91, 1.29)
P = 0.39
1.04 (0.881, 1.24)
P = 0.63
1.06 (0.88, 1.29)
P = 0.54
1.17 (0.96, 1.43)
P = 0.13
Milki 1.16 (0.99, 1.36)
P = 0.06
1.10 (0.94, 1.29)
P = 0.23
1.14 (0.96, 1.34)
P = 0.13
1.17 (0.98, 1.39)
P = 0.09
Fermented dairyj 0.85 (0.69, 1.04)
P = 0.11
0.91 (0.75, 1.11)
P = 0.35
0.90 (0.73, 1.11)
P = 0.32
1.01 (0.80, 1.27)
P = 0.97
Cheesek 0.89 (0.73, 1.08)
P = 0.24
0.97 (0.791, 1.19)
P = 0.77
0.98 (0.79, 1.20)
P = 0.81
1.09 (0.87, 1.35)
P = 0.46
The SDs were 271 g/day for total dairy, 179 g/day for high-fat dairy, 260 g/day for low-fat dairy, 268 g/day for milk and milk products, 202 g/
day for milk, 182 g/day for fermented dairy, and 22 g/day for cheese
Bold values are statistically significant (P \ 0.05)
* Due to missings on confounding variables, the number of cases in model 3 is 108 (total: 1,848), and in model 4, this is 93 (total: 1,637)
a Unadjusted
b Adjusted for age and sex
c Adjusted for age, sex, BMI, smoking, educational level, total energy intake, alcohol consumption
d Adjusted as for model 1 with additional adjustment for physical activity and intake of meat, fish, bread, vegetables, fruit, coffee, and tea
e Includes all dairy products except butter
f Defined as all milk products with a fat content [2.0/100 g or cheese products with a fat content [20/100 g
g Defined as all milk products with a fat content \2.0/100 g or cheese products with a fat content \20/100 g
h Includes all kinds of milk, yoghurt, coffee creamer, curd, cream, porridge, and pudding (both low-fat and high-fat)
i Includes all milk: skimmed, semi-skimmed, and whole milk
j Includes all fermented products, such as yogurt, buttermilk, curds, and cheese products
k Includes soft cheese and hard cheese (both low-fat and high-fat)
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risk of CVD mortality. On the other hand, additional
adjustment for saturated fat moderately reduced the asso-
ciation between high-fat dairy and CVD mortality, but
remained statistically significant. It is therefore very well
possible that besides saturated fat, there are other,
unknown, components or mechanisms that could exert an
effect on the risk of CVD mortality [34]. The consumption
of high-fat dairy might for example reflect more unhealthy
lifestyle or dietary pattern, which was not all measured.
Residual confounding cannot be completely ruled out.
Furthermore, when physical activity, the confounder with
the largest number of missing values (n = 255), was
removed from the final model, the hazard ratio became
lower (HR, 1.24; 95 % CI, 1.03, 1.49), but remained sta-
tistically significant. Caution is therefore needed with the
conclusion that each SD increase in high-fat dairy intake
would be associated with a 32 % higher risk of CVD
mortality.
There is growing evidence for a protective effect of low-
fat dairy on blood pressure [13–15]. The mechanism by
which especially low-fat dairy exerts a beneficial effect on
blood pressure remains to be established. Vitamin K2,
naturally present in fermented dairy products, has been
recently suggested to decrease aortic calcification and CHD
[35, 36].
In this study, fermented dairy and low-fat dairy were not
statistically significantly associated with CVD mortality or
all-cause mortality. Bernstein et al. [37] reported inverse
associations between low-fat dairy and CHD only after
26 years of follow-up. It might be possible that the bene-
ficial effect of fermented and low-fat dairy on CVD
becomes visible after longer exposure and thus longer
follow-up time.
Several strengths and limitations of our study need to be
addressed. In the Netherlands, the intake of dairy products
is naturally high, with a wide variety of dairy products that
Table 3 Hazard ratios (HRs) and 95 % CIs of total mortality per SD increase of dairy intake
Total mortality (n = 403)*
Model 1a Model 2b Model 3c Model 4d
Total dairye 0.91 (0.82, 1.01)
P = 0.06
0.89 (0.81, 0.99)
P = 0.03
0.93 (0.83, 1.04)
P = 0.23
0.97 (0.86, 1.09)
P = 0.61
High-fat dairyf 1.01 (0.91, 1.11)
P = 0.93
0.98 (0.89, 1.08)
P = 0.71
1.00 (0.90, 1.11)
P = 0.98
1.02 (0.90, 1.16)
P = 0.72
Low-fat dairyg 0.90 (0.81, 1.00)
P = 0.04
0.90 (0.82, 1.00)
P = 0.05
0.94 (0.85, 1.05)
P = 0.27
0.96 (0.86, 1.08)
P = 0.50
Milk and milk productsh 0.92 (0.83, 1.02)
P = 0.11
0.90 (0.81, 0.99)
P = 0.04
0.94 (0.84, 1.05)
P = 0.25
0.97 (0.86, 1.09)
P = 0.61
Milki 0.96 (0.87, 1.06)
P = 0.39
0.92 (0.83, 1.01)
P = 0.09
0.96 (0.86, 1.07)
P = 0.43
0.96 (0.86, 1.08)
P = 0.53
Fermented dairyj 0.87 (0.78, 0.97)
P = 0.01
0.92 (0.83, 1.02)
P = 0.12
0.95 (0.85, 1.06)
P = 0.33
0.98 (0.87, 1.11)
P = 0.77
Cheesek 0.84 (0.75, 0.94)
P = 0.002
0.90 (0.80, 1.00)
P = 0.06
0.93 (0.83, 1.05)
P = 0.26
0.96 (0.84, 1.09)
P = 0.51
The SDs were 271 g/day for total dairy, 179 g/day for high-fat dairy, 260 g/day for low-fat dairy, 268 g/day for milk and milk products, 202 g/
day for milk, 182 g/day for fermented dairy, and 22 g/day for cheese
Bold values are statistically significant (P \ 0.05)
* Due to missings on confounder variables, the number of cases in model 3 is 380 (total, 1,848), and in model 4 this is 332 (total, 1,637)
a Unadjusted
b Adjusted for age and sex
c Adjusted for age, sex, BMI, smoking, educational level, total energy intake, alcohol consumption
d Adjusted as for model 1 with additional adjustment for physical activity and intake of meat, fish, bread, vegetables, fruit, coffee, and tea
e Includes all dairy products except butter
f Defined as all milk products with a fat content [2.0/100 g or cheese products with a fat content [20/100 g
g Defined as all milk products with a fat content \2.0/100 g or cheese products with a fat content \20/100 g
h Includes all kinds of milk, yoghurt, coffee creamer, curd, cream, porridge, and pudding (both low-fat and high-fat)
i Includes all milk: skimmed, semi-skimmed, and whole milk
j Includes all fermented products, such as yogurt, buttermilk, curds, and cheese products
k Includes soft cheese and hard cheese (both low-fat and high-fat)
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are consumed. To put this in perspective, in the most recent
European Nutrition and Health report, the highest con-
sumption of milk- and dairy-based products was reported in
countries like Norway (522 g/day), Finland (437 g/day),
the Netherlands (388 g/day), and United Kingdom (320
g/day), whereas intake was low in Austria (171 g/day),
Poland (181 g/day), and the Czech Republic (186 g/day)
[38]. In our data, the mean intake of dairy (466 g/day) was
higher than in this report (mean dairy intake 266 g/capita/
day over 16 European countries) with a large variation,
which enabled us to examine the relationship between
dairy food consumption and CVD over a broad range of
intake.
A possible limitation is the estimation of dairy intake
used in the analysis, which was derived from a semi-
quantitative FFQ. The self-report of usual dietary intake
could lead to misclassification. However, the FFQ was
validated by comparison with a modified dietary history.
Pearson correlation coefficients for estimates from the
questionnaire and dietary history were on average 0.71
(range, 0.65–0.78) for macronutrients and 0.66 (range,
0.36–0.81) for vitamins and minerals [23]. Although the
FFQ was not validated for dairy intake, high correlations
were found for protein and calcium (0.69 and 0.75,
respectively). Moreover, in the Netherlands, dairy is con-
sumed on typical moments during the day, often during
breakfast and/or lunch and after a hot meal, making it
easier for the participants to recall the usual dairy intake.
A limitation of our study is that only dairy consumption
at baseline was investigated, and not during follow-up.
Participants may have changed their dietary pattern during
the study. Although it cannot be assumed, 50- to 75-year-
old adults may be less likely to change nutritional habits.
Another limitation is that we had a limited number of
CVD and all-cause mortality cases. Therefore, we could
not carry out analyses for dairy consumption by tertiles and
presented continuous analyses per SD. Furthermore, no
information on CVD morbidity was available. The partic-
ipants had to give permission to access their hospital
records, which only a small number of people did. It was
therefore only possible to assess the relationship with
mortality, and not with morbidity.
At last, a remark should be made about the age of the
population. This study population was somewhat older than
other cohorts, with an age between 50 and 75 years at
baseline. Caution is needed with generalizing these results
to a younger population.
In this Dutch prospective cohort study, the intake of
high-fat dairy products was associated with an increased
risk of CVD mortality.
Based on the results of this study, it can indeed be
recommended to rather consume low-fat dairy instead of
high-fat dairy in order to reduce the risk of CVD. However,
to draw valuable conclusions, more research is needed in
larger prospective studies with sufficient cases of stroke
and CHD.
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